Advertisement

Topics

Eisai and Ono Pharma to conduct Phase Ib combination trial for liver cancer

19:00 EDT 10 Sep 2017 | Net Resources International

Eisai and Ono Pharmaceutical are planning to conduct a Phase Ib clinical trial of Lenvima (lenvatinib mesylate) in combination with Opdivo (nivolumab), as part of their collaboration agreement to jointly develop the therapy for hepatocellular carcino…

Original Article: Eisai and Ono Pharma to conduct Phase Ib combination trial for liver cancer

NEXT ARTICLE

More From BioPortfolio on "Eisai and Ono Pharma to conduct Phase Ib combination trial for liver cancer"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...